Overview

Asacol Acute Diverticulitis(DIVA)Study

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Asacol® 2.4 g/day (400 mg Mesalamine) is safe and effective in the treatment of diverticulitis.
Phase:
Phase 2
Details
Lead Sponsor:
Warner Chilcott
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Mesalamine